Company Name:Merck Canada Inc.
Nature of Business:Pharmaceutical research, and the marketing and sale of hundreds of pharmaceutical and animal health products, in particular in the areas of cardiology, infectious diseases, respiratory, vaccines and women's healthcare, and also in the areas of virology, oncology and diabetes. The Company carries out clinical research and also engages in research and development work in collaboration with Canadian companies and educational institutions.
NAICS:
Drugs and Druggists' Sundries Merchant Wholesalers (42421)
Research and Development in the Physical, Engineering, and Life Sciences (54171)
Address:16750 Route Transcanadienne
Kirkland, QC  H9H 4M7
Canada
Phone:514-428-8600
Toll Free:800-567-2594
Website:http://www.merck.ca
Other Location(s):Ottawa ON, Toronto ON, Mississauga ON, Edmonton AB and Vancouver BC.
Head Office:In United States

Ownership Class:Privately-held subsidiary corporation, 100% owned
Employee Count (as of 2014):975 (2014)
Fiscal Year:Dec 31

Officers:
Chirfi Guindo President & Managing Director

Dr. Mauricio Ede M.D., Ph.D. Medical Director, Medical Affairs


Related Companies:
Merck & Co., Inc., Whitehouse Station NJ, Parent

Company Notes:In November 2009 the parent company of Merck Frosst Canada & Co., Merck & Co., Inc., merged into the parent company of Schering-Plough Canada Inc., Schering-Plough Corporation. Schering-Plough Corporation thereupon changed its name to Merck & Co., Inc. In Canada, Merck Frosst Canada & Co. and Schering-Plough Canada Inc. merged under the Merck name. On October 1, 2014 Merck & Co., Inc. sold its consumer healthcare business, including related activities in Canada, to Bayer AG.

External Links:
CNW:
http://www.newswire.ca/news/merck-canada-inc